Literature DB >> 4982107

The toxicologic and pharmacologic properties of amantadine hydrochloride.

V G Vernier, J B Harmon, J M Stump, T E Lynes, J P Marvel, D H Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4982107     DOI： 10.1016/0041-008x(69)90066-0

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN： 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  40 in total

Review 1.  Antiviral agents: action and clinical use.

Authors:  T W Chang; D R Snydman
Journal:  Drugs       Date:  1979-11       Impact factor: 9.546

2.  Toxic effects of amantadine in patients with renal failure.

Authors:  T S Ing; J T Daugirdas; L S Soung; H L Klawans; S D Mahurkar; J A Hayashi; W P Geis; J E Hano
Journal:  Can Med Assoc J       Date:  1979-03-17       Impact factor: 8.262

3.  Anticataleptic actions of amantadine hydrochloride.

Authors:  G Zetler
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

4.  Failure of amantadine to modify serum growth hormone and insulin levels.

Authors:  F Cavagnini; A E Pontiroli; U Raggi; M Peracchi; A Malinverni
Journal:  Experientia       Date:  1973-05-15

5.  L-dopa and amantadine hydrochloride in extra-pyramidal disorders.

Authors:  J D Parkes; R P Knill-Jones; P J Clements
Journal:  Postgrad Med J       Date:  1971-02       Impact factor: 2.401

6.  Ultrastructural evidence of amantadine and amphetamine noradrenaline releasing action.

Authors:  E Pita; N Perez
Journal:  Experientia       Date:  1977-01-15

7.  Responses of neurones in the cerebral cortex and caudate nucleus to amantadine, amphetamine and dopamine.

Authors:  T W Stone
Journal:  Br J Pharmacol       Date:  1976-01       Impact factor: 8.739

8.  In vitro studies on the possible effects of 1-aminoadamantanes on the serotonergic system in M. Parkinson.

Authors:  W Wesemann; G Dette-Wildenhahn; H Fellehner
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

9.  Adamantane derivatives: a new class of insulin secretagogues.

Authors:  M G Garrino; J C Henquin
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

10.  Amantadine-HCl (Symmetrel) in the management of Parkinson's disease: a double-blind cross-over study.

Authors:  A Barbeau; H Mars; M I Botez; M Joubert
Journal:  Can Med Assoc J       Date:  1971-07-10       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.